世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い



新型出生前診断(NIPT)市場:製品毎(消耗品、試薬、超音波、NGS、PCR、マイクロアレイ)、サービス毎、方式毎、用途毎、エンドユーザ毎(病院、研究室) - 2024年までの世界市場予測

Non Invasive Prenatal Testing (NIPT) Market by Product (Consumables, Reagent, Ultrasound, NGS, PCR, Microarray), Services, Method (cfDNA, Biochemical Markers), Application (Aneuploidy, Microdeletion) & End-User (Hospital, Labs)-Global Forecasts to 2024

 

出版社 出版日電子媒体価格ページ数図表数
MarketsandMarkets
マーケッツアンドマーケッツ
2019年9月 US$ 4,950
シングルユーザライセンス
145p143点

サマリー

幅広い市場に関する調査レポートを出版しているマーケッツアンドマーケッツ(MarketsandMarkets)の新型出生前診断(NIPT)市場に関する調査レポートです。

“Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age.”

The non-invasive prenatal testing market is projected to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019, at a CAGR of 13.5% during the forecast period. Growth in this market is driven by the high risk of chromosomal abnormalities with increasing maternal age, growing preference for non-invasive techniques over invasive methods, improving reimbursement scenario for NIPT, and increasing awareness of NIPT. However, a dearth of skilled professionals is restraining the growth of this market.

“The services segment is expected to grow at the highest CAGR during the forecast period.”

Based on product and service, the NIPT market is segmented into products and services. The services segment is estimated to register the highest growth rate during the forecast period. The rising incidence of genetic disorders, increasing focus on prenatal screening, and government initiatives to provide prenatal testing services are contributing to the growth of this market.

“The diagnostic laboratories segment accounted for the largest share of the NIPT products market in 2018.”

Based on end user, the NIPT products market is classified into diagnostic laboratories and hospitals. In 2018, diagnostic laboratories formed the largest and fastest-growing end users of NIPT products. This can primarily be attributed to factors such as the implementation of initiatives by diagnostic laboratories to provide safe and effective prenatal tests and rising incidence of chromosomal abnormalities.

“Asia to witness high growth during the forecast period.”

By region, the global NIPT market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2018, North America accounted for the largest market share, followed by Europe. On the other hand, Asia is expected to grow at the highest CAGR during the forecast period. The developing healthcare infrastructure, rising awareness programs & conferences, and rising focus of prominent players on expanding their presence in Asia are driving market growth in this region.

The primary interviews conducted for this report can be categorized as follows:

- By Company Type: Tier 1 (32%), Tier 2 (44%), and Tier 3 (24%)
- By Designation: C-level (30%), D-level (34%), and Others (36%)
- By Region: North America (40%), Europe (28%), Asia (20%), and RoW (12%)

List of Companies Profiled in the Report

- Illumina, Inc. (US)
- Thermo Fisher Scientific Inc. (US)
- GE Healthcare (US)
- BGI (China)
- Agilent Technologies, Inc. (US)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- PerkinElmer Inc. (US)
- Laboratory Corporation of America Holdings (LabCorp) (US)
- Natera, Inc. (US)
- Yourgene Health (UK) 

Research Coverage:

This report provides a picture of the global NIPT market. It aims at estimating the size and future growth potential of the market across different segments, such as product & service, application, and region. The NIPT products market is segmented on the basis of method and end user. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall NIPT market and its subsegments. This report will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. It will also enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, challenges, and opportunities.



目次

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 17
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 18
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 18

2 RESEARCH METHODOLOGY 19
2.1 RESEARCH DATA 19
2.1.1 SECONDARY SOURCES 20
2.1.1.1 Key data from secondary sources 20
2.1.2 PRIMARY SOURCES 21
2.1.2.1 Key data from primary sources 21
2.1.2.2 Key industry insights 22
2.2 MARKET SIZE ESTIMATION 23
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 25
2.4 MARKET SHARE ESTIMATION 25
2.5 ASSUMPTIONS FOR THE STUDY 26

3 EXECUTIVE SUMMARY 27

4 PREMIUM INSIGHTS 31
4.1 NON-INVASIVE PRENATAL TESTING: MARKET OVERVIEW 31
4.2 NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION (2019–2024) 31
4.3 NON-INVASIVE PRENATAL TESTING MARKET SHARE, BY METHOD & REGION (2018) 32
4.4 NON-INVASIVE PRENATAL TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 33

5 MARKET OVERVIEW 34
5.1 INTRODUCTION 34
5.1.1 DRIVERS 35
5.1.1.1 High risk of chromosomal abnormalities with increasing
maternal age 35
5.1.1.2 Growing preference for noninvasive techniques over
invasive methods 36
5.1.1.3 Improving reimbursement scenario for NIPT 37
5.1.1.4 Programs focusing on increasing the awareness of NIPT 37
5.1.2 OPPORTUNITIES 38
5.1.2.1 Untapped emerging markets 38
5.1.3 CHALLENGES 39
5.1.3.1 Reliability of test results, especially in obese women 39
5.1.3.2 Lack of skilled professionals 39

6 NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE 40
6.1 INTRODUCTION 41
6.2 PRODUCTS 41
6.2.1 CONSUMABLES 42
6.2.1.1 Assay kits & reagents 44
6.2.1.1.1 North America is the largest market for assay kits & reagents segments 44
6.2.1.2 Disposables 45
6.2.1.2.1 Use of disposables to avoid contamination is one of
the major growth factors for this segment 45
6.2.2 INSTRUMENTS 45
6.2.2.1 Ultrasound devices 48
6.2.2.1.1 Popularity of ultrasound in fetal and embryonic imaging and safety has driven market growth 48
6.2.2.2 Next-generation sequencing systems 48
6.2.2.2.1 NGS systems have found rising use in NIPT 48
6.2.2.3 Polymerase chain reaction instruments 49
6.2.2.3.1 Increasing research in the field of prenatal genetic testing is expected to boost market growth 49
6.2.2.4 Microarrays 50
6.2.2.4.1 Flexibility of chips and short processing times have supported the use of microarrays 50
6.2.2.5 Other instruments 51
6.3 SERVICES 51
6.3.1 NORTH AMERICA SHOWS THE HIGHEST DEMAND FOR TESTING SERVICES 51

7 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD 53
7.1 INTRODUCTION 54
7.2 ULTRASOUND DETECTION 54
7.2.1 ULTRASOUND DETECTION SEGMENT DOMINATES
THE NIPT PRODUCTS MARKET 54
7.3 BIOCHEMICAL SCREENING TESTS 56
7.3.1 HIGH INCIDENCE OF GENETIC DISORDERS & INCREASING FOCUS ON PRENATAL TESTING TO SUPPORT MARKET GROWTH 56
7.4 CELL-FREE DNA IN MATERNAL PLASMA TESTS 58
7.4.1 CELL-FREE DNA IN MATERNAL PLASMA TESTS SEGMENT TO REGISTER
THE HIGHEST CAGR IN THE FORECAST PERIOD 58

8 NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION 61
8.1 INTRODUCTION 62
8.2 TRISOMY 62
8.2.1 TRISOMY FORMS THE LARGEST AND FASTEST-GROWING APPLICATION SEGMENT OF THE NIPT MARKET 62
8.3 MICRODELETION SYNDROME 64
8.3.1 HIGH INCIDENCE OF MICRODELETION SYNDROME IS A KEY FACTOR DRIVING THE GROWTH OF THIS APPLICATION SEGMENT 64
8.4 OTHER APPLICATIONS 66

9 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER 68
9.1 INTRODUCTION 69
9.2 DIAGNOSTIC LABORATORIES 69
9.2.1 INCREASE IN RESEARCH INTENSITY TO DRIVE THE USAGE OF NIPT PRODUCTS AMONG DIAGNOSTIC LABS 69
9.3 HOSPITALS 71
9.3.1 NORTH AMERICA HOLDS THE MAJOR SHARE OF THIS END-USER SEGMENT 71

10 NON-INVASIVE PRENATAL TESTING MARKET, BY REGION 74
10.1 INTRODUCTION 75
10.2 NORTH AMERICA 75
10.2.1 US 79
10.2.1.1 High number of babies born with chromosomal syndromes is a major factor driving the demand for non-invasive prenatal testing in the US 79
10.2.2 CANADA 81
10.2.2.1 Unfavorable reimbursement scenario for non-invasive prenatal testing is a key challenge for market growth in Canada 81
10.3 EUROPE 84
10.3.1 FRANCE 88
10.3.1.1 Favorable insurance coverage for prenatal testing to increase the adoption of NIPT in France 88
10.3.2 UK 90
10.3.2.1 High incidence of genetic abnormalities to increase the demand for prenatal testing procedures in the UK 90
10.3.3 GERMANY 92
10.3.3.1 Increasing healthcare spending—a major factor contributing to market growth in Germany 92
10.3.4 REST OF EUROPE 94
10.4 ASIA 96
10.4.1 HIGH COST OF NIPT PRODUCTS IS A MAJOR FACTOR LIMITING MARKET GROWTH IN ASIA DURING THE FORECAST PERIOD 96
10.5 REST OF THE WORLD 100

11 COMPETITIVE LANDSCAPE 104
11.1 OVERVIEW 104
11.2 MARKET PLAYER RANKING 105
11.3 COMPETITIVE LEADERSHIP MAPPING – PRODUCT MARKET 106
11.3.1 VISIONARY LEADERS 106
11.3.2 INNOVATORS 106
11.3.3 DYNAMIC DIFFERENTIATORS 106
11.3.4 EMERGING PLAYERS 106
11.4 COMPETITIVE SITUATION AND TRENDS 108
11.4.1 PRODUCT & SERVICES LAUNCHES 108
11.4.2 EXPANSIONS 109
11.4.3 ACQUISITIONS 110
11.4.4 OTHER STRATEGIES 111

12 COMPANY PROFILE 112
(Business Overview, Products and Services Offered, Recent Developments, and MnM View)*
12.1 ILLUMINA, INC. 112
12.2 THERMO FISHER SCIENTIFIC, INC. 115
12.3 GE HEALTHCARE (A WHOLLY OWNED SUBSIDIARY OF GENERAL ELECTRIC COMPANY) 118
12.4 PERKINELMER, INC. 120
12.5 AGILENT TECHNOLOGIES, INC. 123
12.6 BEIJING GENOMICS INSTITUTE 125
12.7 F. HOFFMAN-LA ROCHE LTD. 127
12.8 LABORATORY CORPORATION OF AMERICA HOLDINGS 129
12.9 NATERA, INC. 132
12.10 YOURGENE HEALTH 134
* Business Overview, Products and Services Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

13 APPENDIX 137
13.1 DISCUSSION GUIDE 137
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 141
13.3 AVAILABLE CUSTOMIZATIONS 143
13.4 RELATED REPORTS 143
13.5 AUTHOR DETAILS 144

 

LIST OF TABLES

TABLE 1 INCIDENCE RATE OF TRISOMY 35
TABLE 2 RISK OF DOWN SYNDROME WITH INCREASING MATERNAL AGE (GLOBALLY) 36
TABLE 3 COMPARISON OF NON-INVASIVE AND INVASIVE PRENATAL TESTING 36
TABLE 4 NIPT REIMBURSEMENT SCENARIO, BY COUNTRY 37
TABLE 5 PUBLIC HEALTHCARE EXPENDITURE (% OF GDP) 38
TABLE 6 NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 41
TABLE 7 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 41
TABLE 8 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY REGION,
2017–2024 (USD MILLION) 42
TABLE 9 NIPT CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION) 42
TABLE 10 NIPT CONSUMABLES MARKET, BY REGION, 2017–2024 (USD MILLION) 43
TABLE 11 NORTH AMERICA: NIPT CONSUMABLES MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 43
TABLE 12 EUROPE: NIPT CONSUMABLES MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 43
TABLE 13 NIPT ASSAY KITS AND REAGENTS MARKET, BY REGION,
2017–2024 (USD MILLION) 44
TABLE 14 NIPT DISPOSABLES MARKET, BY REGION, 2017–2024 (USD MILLION) 45
TABLE 15 NIPT INSTRUMENTS MARKET, BY TYPE, 2017–2024 (USD MILLION) 46
TABLE 16 NIPT INSTRUMENTS MARKET, BY REGION, 2017–2024 (USD MILLION) 46
TABLE 17 NORTH AMERICA: NIPT INSTRUMENTS MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 47
TABLE 18 EUROPE: NIPT INSTRUMENTS MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 47
TABLE 19 NIPT ULTRASOUND DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 48
TABLE 20 NIPT NEXT-GENERATION SEQUENCING SYSTEMS MARKET, BY REGION,
2017–2024 (USD MILLION) 49
TABLE 21 NIPT PCR INSTRUMENTS MARKET, BY REGION, 2017–2024 (USD MILLION) 50
TABLE 22 NIPT MICROARRAYS MARKET, BY REGION, 2017–2024 (USD MILLION) 50
TABLE 23 OTHER NIPT INSTRUMENTS MARKET, BY REGION, 2017–2024 (USD MILLION) 51
TABLE 24 NIPT SERVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 52
TABLE 25 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD,
2017–2024 (USD MILLION) 54
TABLE 26 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR ULTRASOUND DETECTION, BY REGION, 2017–2024 (USD MILLION) 55
TABLE 27 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR ULTRASOUND DETECTION, BY COUNTRY, 2017–2024 (USD MILLION) 55
TABLE 28 EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR ULTRASOUND DETECTION, BY COUNTRY, 2017–2024 (USD MILLION) 56
TABLE 29 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR BIOCHEMICAL SCREENING TESTS, BY REGION, 2017–2024 (USD MILLION) 57
TABLE 30 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR BIOCHEMICAL SCREENING TESTS, BY COUNTRY, 2017–2024 (USD MILLION) 57
TABLE 31 EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR BIOCHEMICAL SCREENING TESTS, BY COUNTRY, 2017–2024 (USD MILLION) 58
TABLE 32 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR CFDNA IN
MATERNAL PLASMA TESTS, BY REGION, 2017–2024 (USD MILLION) 59
TABLE 33 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR CFDNA IN MATERNAL PLASMA TESTS, BY COUNTRY, 2017–2024 (USD MILLION) 59
TABLE 34 EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR CFDNA IN MATERNAL PLASMA TESTS, BY COUNTRY, 2017–2024 (USD MILLION) 60
TABLE 35 NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 62
TABLE 36 NON-INVASIVE PRENATAL TESTING MARKET FOR TRISOMY, BY REGION,
2017–2024 (USD MILLION) 63
TABLE 37 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET FOR TRISOMY,
BY COUNTRY, 2017–2024 (USD MILLION) 63
TABLE 38 EUROPE: NON-INVASIVE PRENATAL TESTING MARKET FOR TRISOMY,
BY COUNTRY, 2017–2024 (USD MILLION) 64
TABLE 39 NON-INVASIVE PRENATAL TESTING MARKET FOR MICRODELETION SYNDROME,
BY REGION, 2017–2024 (USD MILLION) 65
TABLE 40 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET FOR MICRODELETION SYNDROME, BY COUNTRY, 2017–2024 (USD MILLION) 65
TABLE 41 EUROPE: NON-INVASIVE PRENATAL TESTING MARKET FOR MICRODELETION SYNDROME, BY COUNTRY, 2017–2024 (USD MILLION) 66
TABLE 42 NON-INVASIVE PRENATAL TESTING MARKET FOR OTHER APPLICATIONS,
BY REGION, 2017–2024 (USD MILLION) 66
TABLE 43 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET FOR
OTHER APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION) 67
TABLE 44 EUROPE: NON-INVASIVE PRENATAL TESTING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2017–2024 (USD MILLION) 67
TABLE 45 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER,
2017–2024 (USD MILLION) 69
TABLE 46 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2017–2024 (USD MILLION) 70
TABLE 47 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET
FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2017–2024 (USD MILLION) 70
TABLE 48 EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2017–2024 (USD MILLION) 71
TABLE 49 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR HOSPITALS,
BY REGION, 2017–2024 (USD MILLION) 72
TABLE 50 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR HOSPITALS, BY COUNTRY, 2017–2024 (USD MILLION) 72
TABLE 51 EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET FOR HOSPITALS, BY COUNTRY, 2017–2024 (USD MILLION) 73
TABLE 52 NON-INVASIVE PRENATAL TESTING MARKET, BY REGION,
2017–2024 (USD MILLION) 75
TABLE 53 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET,
BY COUNTRY, 2017–2024 (USD MILLION) 76
TABLE 54 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET,
BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 77
TABLE 55 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET,
BY TYPE, 2017–2024 (USD MILLION) 77
TABLE 56 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING CONSUMABLES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 77
TABLE 57 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING INSTRUMENTS MARKET,
BY TYPE, 2017–2024 (USD MILLION) 78
TABLE 58 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET,
BY METHOD, 2017–2024 (USD MILLION) 78
TABLE 59 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 79
TABLE 60 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET,
BY END USER, 2017–2024 (USD MILLION) 79
TABLE 61 US: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 80
TABLE 62 US: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD,
2017–2024 (USD MILLION) 80
TABLE 63 US: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 81
TABLE 64 US: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER,
2017–2024 (USD MILLION) 81
TABLE 65 CANADA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET,
BY TYPE, 2017–2024 (USD MILLION) 82
TABLE 66 CANADA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET,
BY METHOD, 2017–2024 (USD MILLION) 82
TABLE 67 CANADA: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 83
TABLE 68 CANADA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION) 83
TABLE 69 EUROPE: NON-INVASIVE PRENATAL TESTING MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 85
TABLE 70 EUROPE: NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 85
TABLE 71 EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET,
BY TYPE, 2017–2024 (USD MILLION) 85
TABLE 72 EUROPE: NON-INVASIVE PRENATAL TESTING CONSUMABLES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 86
TABLE 73 EUROPE: NON-INVASIVE PRENATAL TESTING INSTRUMENTS MARKET,
BY TYPE, 2017–2024 (USD MILLION) 86
TABLE 74 EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET,
BY METHOD, 2017–2024 (USD MILLION) 87
TABLE 75 EUROPE: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 87
TABLE 76 EUROPE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION) 87
TABLE 77 FRANCE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 88
TABLE 78 FRANCE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET,
BY METHOD, 2017–2024 (USD MILLION) 89
TABLE 79 FRANCE: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 89
TABLE 80 FRANCE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION) 89
TABLE 81 UK: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 90
TABLE 82 UK: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD,
2017–2024 (USD MILLION) 91
TABLE 83 UK: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 91
TABLE 84 UK: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER,
2017–2024 (USD MILLION) 91
TABLE 85 GERMANY: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET,
BY TYPE, 2017–2024 (USD MILLION) 92
TABLE 86 GERMANY: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET,
BY METHOD, 2017–2024 (USD MILLION) 93
TABLE 87 GERMANY: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 93
TABLE 88 GERMANY: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION) 93
TABLE 89 THE TABLE BELOW MENTIONS THE MEAN MATERNAL AGE AT FIRST BIRTH IN
ROE COUNTRIES: 94
TABLE 90 ROE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 95
TABLE 91 ROE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD,
2017–2024 (USD MILLION) 95
TABLE 92 ROE: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 95
TABLE 93 ROE: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION) 96
TABLE 94 ASIA: NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 97
TABLE 95 ASIA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 97
TABLE 96 ASIA: NON-INVASIVE PRENATAL TESTING CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION) 97
TABLE 97 ASIA: NON-INVASIVE PRENATAL TESTING INSTRUMENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 98
TABLE 98 ASIA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD,
2017–2024 (USD MILLION) 98
TABLE 99 ASIA: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 99
TABLE 100 ASIA: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER, 2017–2024 (USD MILLION) 99
TABLE 101 ROW: NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 100
TABLE 102 ROW: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 101
TABLE 103 ROW: NON-INVASIVE PRENATAL TESTING CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION) 101
TABLE 104 ROW: NON-INVASIVE PRENATAL TESTING INSTRUMENTS MARKET, BY TYPE,
2017–2024 (USD MILLION) 102
TABLE 105 ROW: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD, 2017–2024 (USD MILLION) 102
TABLE 106 ROW: NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 103
TABLE 107 ROW: NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET,
BY END USER, 2017–2024 (USD MILLION) 103
TABLE 108 PRODUCT AND SERVICE LAUNCHES, 2016–2018 108
TABLE 109 EXPANSIONS, 2016–2018 109
TABLE 110 ACQUISITIONS, 2016–2018 110
TABLE 111 OTHER STRATEGIES, 2016–2018 111
TABLE 112 EXCHANGE RATE (USED FOR THE CONVERSION OF GBP TO USD) 134

 

LIST OF FIGURES

FIGURE 1 NON-INVASIVE PRENATAL TESTING MARKET SEGMENTATION 17
FIGURE 2 RESEARCH DESIGN 19
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS 22
FIGURE 4 BOTTOM-UP APPROACH 23
FIGURE 5 TOP-DOWN APPROACH 24
FIGURE 6 DATA TRIANGULATION METHODOLOGY 25
FIGURE 7 NON-INVASIVE PRENATAL TESTING MARKET, BY PRODUCT & SERVICE,
2019 VS. 2024 (USD MILLION) 27
FIGURE 8 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY TYPE,
2019 VS. 2024 (USD MILLION) 28
FIGURE 9 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY METHOD,
2019 VS. 2024 (USD MILLION) 28
FIGURE 10 NON-INVASIVE PRENATAL TESTING PRODUCTS MARKET, BY END USER,
2019 VS. 2024 (USD MILLION) 29
FIGURE 11 NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION 29
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE NON-INVASIVE PRENATAL TESTING MARKET 30
FIGURE 13 HIGH RISK OF CHROMOSOMAL ABNORMALITIES WITH INCREASING
MATERNAL AGE IS A MAJOR FACTOR DRIVING THE ADOPTION OF
NON-INVASIVE PRENATAL TESTING 31
FIGURE 14 TRISOMY IS THE FASTEST-GROWING APPLICATION SEGMENT OF THE NIPT MARKET 31
FIGURE 15 ULTRASOUND DETECTION SEGMENT ACCOUNTED FOR
THE LARGEST MARKET SHARE IN 2018 32
FIGURE 16 THE NIPT MARKET IN ASIA TO REGISTER THE HIGHEST GROWTH DURING
THE FORECAST PERIOD (2019–2024) 33
FIGURE 17 NIPT MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES 34
FIGURE 18 NORTH AMERICA: NON-INVASIVE PRENATAL TESTING MARKET SNAPSHOT 76
FIGURE 19 EUROPE: NON-INVASIVE PRENATAL TESTING MARKET SNAPSHOT 84
FIGURE 20 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH
STRATEGIES BETWEEN 2016-2018 104
FIGURE 21 GLOBAL NON-INVASIVE PRENATAL TESTING MARKET PLAYER RANKING
FOR PRODUCT, 2018 105
FIGURE 22 NIPT MARKET – PRODUCT MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2018 107
FIGURE 23 ILLUMINA, INC.: COMPANY SNAPSHOT (2018) 112
FIGURE 24 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2018) 115
FIGURE 25 GE HEALTHCARE: COMPANY SNAPSHOT (2018) 118
FIGURE 26 PERKINELMER, INC.: COMPANY SNAPSHOT (2018) 120
FIGURE 27 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2018) 123
FIGURE 28 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2018) 127
FIGURE 29 LABCORP: COMPANY SNAPSHOT (2018) 129
FIGURE 30 NATERA, INC.: COMPANY SNAPSHOT (2018) 132
FIGURE 31 YOURGENE HEALTH.: COMPANY SNAPSHOT (2018) 134
 

 

COPYRIGHT(C) 2011-2019 DATA RESOURCES, Inc. ALL RIGHTS RESERVED.